BioCentury
ARTICLE | Company News

Genetic Technologies, ImmunAid Ltd. other news

January 6, 2014 8:00 AM UTC

Genetic Technologies said on Dec. 18, 2013, that founder Mervyn Jacobson's equity stake in the company will be reduced to 6.15% from 23.83% following his disposal of 105.9 million shares. Jacobsen dis...